Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$732 Mln
Revenue (TTM)
$1,176 Mln
Net Profit (TTM)
$37 Mln
ROE
0.4 %
ROCE
-- %
P/E Ratio
19.7
P/B Ratio
5.8
Industry P/E
16.87
EV/EBITDA
13.3
Div. Yield
0 %
Debt to Equity
3.7
Book Value
$--
EPS
$0.9
Face value
--
Shares outstanding
39,123,300
CFO
$724.29 Mln
EBITDA
$482.22 Mln
Net Profit
$-237.38 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Hanger (HNGR)
| 3.3 | 0.3 | 27.8 | -16.2 | -1.3 | 10.6 | -4.1 |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
|---|---|---|---|---|---|---|---|
|
Hanger (HNGR)
| -17.6 | -20.4 | 45.7 | 20.2 | 37.0 | -30.1 | -24.9 |
|
S&P Small-Cap 600
| 25.3 | 9.6 | 20.9 | -9.7 | 11.7 | 24.7 | -3.4 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 | -5.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Hanger (HNGR)
|
18.7 | 732.4 | 1,175.5 | 37.3 | 5.8 | 31.7 | 19.7 | 5.8 |
| 27.5 | 9,025.2 | 3,497.4 | -77.0 | 4.3 | -2.4 | -- | 2.7 | |
| 68.5 | 4,621.4 | 234.9 | -322.5 | -126.6 | -204.9 | -- | 39.0 |
Hanger, Inc. provides orthotic and prosthetic (O&P) services in the United States. It operates in two segments, Patient Care and Products & Services. The Patient Care segment owns and operates Hanger clinic, which specializes in the design,... fabrication, and delivery of custom O&P devices through patient care clinics and satellite locations; and offers payor network contracting services to other O&P providers. The Products & Services segment engages in the distribution of various O&P parts, componentry, and devices to independent O&P providers; development of specialized rehabilitation technologies; and provision of evidence-based clinical programs for post-acute rehabilitation to patients at approximately 4,000 skilled nursing and post-acute providers. This segment also manufactures and sells therapeutic footwear for diabetic patients in the podiatric market. As of December 31, 2021, the company operated approximately 760 patient care clinics and 115 satellite locations in 47 states and the District of Columbia. It also distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings. The company was formerly known as Hanger Orthopedic Group, Inc. and changed its name to Hanger, Inc. in June 2012. Hanger, Inc. was founded in 1861 and is headquartered in Austin, Texas. Read more
CEO, Pres & Director
Mr. Vinit K. Asar
CFO & Exec. VP
Mr. Thomas E. Kiraly
Headquarters
Austin, TX
Website
The share price of Hanger Inc (HNGR) is $18.72 (NYSE) as of 03-Oct-2022 09:30 EDT. Hanger Inc (HNGR) has given a return of -1.32% in the last 3 years.
The P/E ratio of Hanger Inc (HNGR) is 19.71 times as on 03-Oct-2022, a 17 premium to its peers’ median range of 16.87 times.
The P/B ratio of Hanger Inc (HNGR) is 5.85 times as on 03-Oct-2022, a 252 premium to its peers’ median range of 1.66 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
16.90
|
6.44
|
|
2020
|
22.40
|
16.79
|
|
2019
|
38.53
|
111.60
|
|
2018
|
-833.13
|
-32.60
|
|
2017
|
-5.32
|
8.65
|
The 52-week high and low of Hanger Inc (HNGR) are Rs -- and Rs -- as of 03-Apr-2026.
Hanger Inc (HNGR) has a market capitalisation of $ 732 Mln as on 03-Oct-2022. As per SEBI classification, it is a Small Cap company.
Before investing in Hanger Inc (HNGR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.